Evidence map›Paper›PMID 34443519›Full record

ArticleMolecules (Basel, Switzerland)2021

Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP

Christopher R Apostol, Parthasaradhireddy Tanguturi, Lajos Z Szabò, Daniel Varela, Thiago Gilmartin, John M Streicher, Robin Polt

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Christopher R ApostolDepartment of Chemistry and Biochemistry, BIO5, The University of Arizona, 1306 E. University Blvd, Tucson, AZ 85721, USA.
Parthasaradhireddy TanguturiDepartment of Pharmacology, College of Medicine, The University of Arizona, 1501 N. Campbell Ave, Tucson, AZ 85724, USA.ORCID 0000-0002-2566-9312
Lajos Z SzabòDepartment of Chemistry and Biochemistry, BIO5, The University of Arizona, 1306 E. University Blvd, Tucson, AZ 85721, USA.
Daniel VarelaFacultat de Quìmica Tarragona, Universitat Rovera I Virgili, 43007 Barcelona, Spain.
Thiago GilmartinFacultat de Quìmica Tarragona, Universitat Rovera I Virgili, 43007 Barcelona, Spain.
John M StreicherDepartment of Pharmacology, College of Medicine, The University of Arizona, 1501 N. Campbell Ave, Tucson, AZ 85724, USA.
Robin PoltDepartment of Chemistry and Biochemistry, BIO5, The University of Arizona, 1306 E. University Blvd, Tucson, AZ 85721, USA.
University of Arizona · USUniversitat Rovira i Virgili · ES

Funding

PACAP/VIP Glycopeptide Agonists as Neuroprotective Therapies for Parkinson's DiseaseR01NS091238 · NINDS · UNIVERSITY OF ARIZONA · PI POLT, ROBIN · 2015 to 2019
$2.0M
NINDS NIH HHS R01NS091238
6 · The paper itself

Abstract

The search for efficacious treatment of neurodegenerative and progressive neuroinflammatory diseases continues, as current therapies are unable to halt or reverse disease progression. PACAP represents one potential therapeutic that provides neuroprotection effects on neurons, and also modulates inflammatory responses and circulation within the brain. However, PACAP is a relatively long peptide hormone that is not trivial to synthesize. Based on previous observations that the shortened isoform PACAP

Indexed as

BrainGlycopeptidesHumansInflammationNeurodegenerative DiseasesNeuroprotective AgentsPeptide FragmentsPeptide HormonesReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IReceptors, Vasoactive Intestinal Peptide, Type IIReceptors, Vasoactive Intestinal Polypeptide, Type IGlycopeptidesNeuroprotective AgentsPeptide FragmentsPeptide HormonesReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IReceptors, Vasoactive Intestinal Peptide, Type IIReceptors, Vasoactive Intestinal Polypeptide, Type IAlzheimer’sglycopeptideglycosylationParkinson’sstroke

Identifiers

PMID34443519
PMCPMC8401035
OpenAlexW3195111351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.